2009年2月
Comparison of efficacy between continuous hemodiafiltration with a PMMA membrane hemofilter and a PAN membrane hemofilter in the treatment of a patient with septic acute renal failure
TRANSFUSION AND APHERESIS SCIENCE
- ,
- ,
- ,
- 巻
- 40
- 号
- 1
- 開始ページ
- 49
- 終了ページ
- 53
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.transci.2008.11.003
- 出版者・発行元
- PERGAMON-ELSEVIER SCIENCE LTD
The aim of this study was to investigate whether PMMA-CHDF in the treatment of a patient with septic acute renal failure (septic ARF) is clinically relevant. Thirteen patients were treated with PMMA-CHDF. Thirteen patients were treated with PAN-CHDF. The urinary output significantly increased in PMMA-CHDF group following 24 h of the treatment (p < 0.05), whereas those did not improve in PAN-CHDF group. The 28-day survival was 84.6% in PMMA-CHDF group and 38.5%, in PAN-CHDF group, respectively (p < 0.05). We can assume that the cytokine modulation with PMMA-CHDF in the treatment of patients with septic ARF is clinically relevant. (C) 2008 Elsevier Ltd. All rights reserved.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.transci.2008.11.003
- ISSN : 1473-0502
- Web of Science ID : WOS:000264428700008